Clesrovimab, sold under the brand name Enflonsia, is a fully human immunoglobulin G1 kappa monoclonal antibody designed to prevent respiratory syncytial virus infection. It is a respiratory syncytial virus F protein-directed fusion inhibitor. From Wikipedia
